Product Images Gabapentin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Gabapentin NDC 16714-332 by Northstar Rx Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - gabapentin fig1
This appears to be a formula for calculating Lt (likely meaning "renal function" or "glomerular filtration rate") based on a person's age and weight multiplied by their creatinine measurement. The creatinine measurement given is specific to female patients. However, without additional context it is impossible to determine the purpose or significance of this formula.*
Figure 1. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 1 - gabapentin fig2
The text provides a figure and a graph displaying the mean pain scores observed cases in ITT Population for Study 1 during the 4Week Dose Tiation Perod and 4Week Fixed Duse Period. The graph compares the placebo and gabapentin 3600 mg/day group. There is no further information available to provide additional context.*
Figure 2. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 2 - gabapentin fig3
The text describes a graph of weekly mean pain scores in a study. The study had a 10 to 3-week dose titration period and a 4-week fixed dose period. The graph shows the observed cases in the ITT population. The graph includes a placebo, gabapentin (1800 mg/day) and gabapentin (2400 mg/day). The graph displays the mean pain score at baseline and weeks 1 to 7.*
Figure 3. Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies - gabapentin fig4
The text describes a chart showing the proportion of responders in controlled PHN studies. The chart shows the percentage of patients who experienced a reduction in pain score of 250% at the end of the study. The chart has two labeled studies (Study 1 and Study 2) with a corresponding percentage of responders. There are also labels for PBO, GBP1800, GBP200, PBO 6BP, and 3600.*
Figure 4. Responder Rate in Patients Receiving Gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - gabapentin fig5
This appears to be a figure with a graph showing the responder rate of patients receiving Gabapentin as an Adjunctive Therapy in the treatment of Partial Seizures. The graph shows the difference in responder rate between Gabapentin and Placebo for different doses of Gabapentin ranging from 600mg to 1800mg daily dose. Therefore, there is no useful description to give.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – 600 mg (100 Tablets Bottle) - gabapentin fig6
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL – 800 mg (100 Tablets Bottle) - gabapentin fig7
This is a description for a medication called Gabapentin, manufactured by Aurobindo Pharma Limited. Each film-coated tablet contains 800mg of Gabapentin and the recommended dosage is available in the package insert. Northstar Rx LLC is the company that the medication was manufactured for and the product can be obtained through their website or by phone. There are 100 tablets in the package and the medication should be stored at 20 to 25 degrees Celsius. The instruction also recommends that the pharmacist dispense the medication guide provided separately to each patient.*
Chemical Structure - gabapentin str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.